These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9717816

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Gö 6976 is a potent inhibitor of neurotrophin-receptor intrinsic tyrosine kinase.
    Behrens MM, Strasser U, Choi DW.
    J Neurochem; 1999 Mar; 72(3):919-24. PubMed ID: 10037462
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
    Zhu Q, Yang J, Han S, Liu J, Holzbeierlein J, Thrasher JB, Li B.
    Prostate; 2011 Jun 01; 71(8):835-45. PubMed ID: 21456066
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.
    Epner DE, Partin AW, Schalken JA, Isaacs JT, Coffey DS.
    Cancer Res; 1993 May 01; 53(9):1995-7. PubMed ID: 8481901
    [Abstract] [Full Text] [Related]

  • 52. Observations with an S-adenosylmethionine decarboxylase inhibitor in rats with prostatic adenocarcinoma.
    Seiler N, Delcros JG, Cipolla B, Chamaillard L, Havouis R, Quemener V, Moulinoux JP.
    Arzneimittelforschung; 1996 Mar 01; 46(3):311-5. PubMed ID: 8901156
    [Abstract] [Full Text] [Related]

  • 53. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology.
    Drago JR, Gershwin ME, Maurer RE, Ikeda RM, Eckels DD.
    J Natl Cancer Inst; 1979 Apr 01; 62(4):1057-66. PubMed ID: 285279
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment.
    Festuccia C, Gravina GL, Muzi P, Millimaggi D, Dolo V, Vicentini C, Ficorella C, Ricevuto E, Bologna M.
    Prostate; 2009 Mar 01; 69(4):337-45. PubMed ID: 19016477
    [Abstract] [Full Text] [Related]

  • 56. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
    Lowe FC, Isaacs JT.
    Cancer Res; 1984 Feb 01; 44(2):744-52. PubMed ID: 6537899
    [Abstract] [Full Text] [Related]

  • 57. The Dunning tumors.
    Lubaroff DM, Canfield L, Reynolds CW.
    Prog Clin Biol Res; 1980 Feb 01; 37():243-63. PubMed ID: 6247719
    [Abstract] [Full Text] [Related]

  • 58. Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.
    Gravina GL, Marampon F, Sanità P, Mancini A, Colapietro A, Scarsella L, Jitariuc A, Biordi L, Ficorella C, Festuccia C.
    Oncol Rep; 2016 Jul 01; 36(1):125-30. PubMed ID: 27222100
    [Abstract] [Full Text] [Related]

  • 59. Comparative pathology of benign prostatic hyperplasia and prostate cancer.
    Maini A, Archer C, Wang CY, Haas GP.
    In Vivo; 1997 Jul 01; 11(4):293-9. PubMed ID: 9292295
    [Abstract] [Full Text] [Related]

  • 60. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
    Drago JR, Goldman LB, Gershwin ME.
    Prog Clin Biol Res; 1980 Jul 01; 37():325-63. PubMed ID: 7384092
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.